HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $447,590 | -1.4% | 11,717 | -6.9% | 0.02% | +4.2% |
| Q2 2023 | $453,797 | +7.0% | 12,581 | +13.2% | 0.02% | -4.0% |
| Q1 2023 | $424,291 | -34.9% | 11,110 | -2.9% | 0.02% | -40.5% |
| Q4 2022 | $651,334 | +34.0% | 11,447 | -6.8% | 0.04% | +23.5% |
| Q3 2022 | $486,000 | -19.8% | 12,284 | -10.8% | 0.03% | -17.1% |
| Q2 2022 | $606,000 | +9.0% | 13,775 | -1.2% | 0.04% | +28.1% |
| Q1 2022 | $556,000 | -0.7% | 13,949 | +0.1% | 0.03% | +3.2% |
| Q4 2021 | $560,000 | -1.6% | 13,931 | -0.4% | 0.03% | -11.4% |
| Q3 2021 | $569,000 | -10.8% | 13,988 | -0.5% | 0.04% | -10.3% |
| Q2 2021 | $638,000 | -7.1% | 14,052 | -12.7% | 0.04% | -17.0% |
| Q4 2020 | $687,000 | – | 16,095 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |